Possibilities of Predicting Methotrexate-associated Toxicity in Oncohematology Based on Molecular Genetic Testing Methods
The development of highly effective protocols for the treatment of acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphomas (NHL) followed the path of escalation of doses of cytostatic agents and improvement of supportive care. Methotrexate (MTX), used in high doses (1000–5000 mg/m2), radically...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Russo |
| Опубліковано: |
Union of pediatricians of Russia
2024-11-01
|
| Серія: | Педиатрическая фармакология |
| Предмети: | |
| Онлайн доступ: | https://www.pedpharma.ru/jour/article/view/2528 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|